Results 1 to 10 of about 212,002 (112)

Insulin‐like peptide 3 in domestic animals with normal and abnormal reproductive functions, in comparison to rodents and humans [PDF]

open access: yesReproductive Medicine and Biology, 2022
Background Insulin‐like peptide 3 (INSL3) is a circulating hormone secreted from only testis and ovaries in mammals. Findings on INSL3 have been gathered from subjects with normal and abnormal reproductive statuses, especially rodents and humans. However,
Noritoshi Kawate
doaj   +2 more sources

Insulin-Like Peptide 3 (INSL3) Serum Concentration During Human Male Fetal Life [PDF]

open access: yesFrontiers in Endocrinology, 2019
Context: Insulin-like peptide 3 (INSL3), a protein hormone produced by Leydig cells, may play a crucial role in testicular descent as male INSL3 knockout mice have bilateral cryptorchidism.
Steven M. Harrison   +8 more
doaj   +2 more sources

Insulin-like peptide 3 is not a biomarker for pancreatic ductal adenocarcinoma [PDF]

open access: yesFrontiers in Endocrinology
Pancreatic ductal carcinoma (PDAC) is a rapidly growing cancer with a very poor prognosis. It is, therefore, important to develop novel, specific biomarkers to identify such cancers as early as possible.
Ravinder Anand-Ivell   +5 more
doaj   +2 more sources

Quantitative analyses of insulin-like peptide 3 and sex steroid hormones in dominant follicles and corpora lutea during the estrus cycle and in follicular cysts in beef heifers [PDF]

open access: yesThe Journal of Reproduction and Development, 2022
Insulin-like peptide 3 (INSL3) and sex steroids were measured in bovine dominant follicles and corpora lutea during the estrus cycle and in follicular cysts.
Hewage Dilhan Anuradha WIMALARATHNE   +2 more
doaj   +2 more sources

The structural determinants of insulin-like peptide 3 activity [PDF]

open access: yesFrontiers in Endocrinology, 2012
INSL3 is a hormone and/or paracrine factor which is a member of the relaxin peptide family. It has key roles as a fertility regulator in both males and females. The receptor for INSL3 is the leucine rich repeat (LRR) containing G-protein coupled receptor
Ross AD Bathgate   +5 more
doaj   +2 more sources

Distinct activation modes of the Relaxin Family Peptide Receptor 2 in response to insulin-like peptide 3 and relaxin [PDF]

open access: yesScientific Reports, 2017
Relaxin family peptide receptor 2 (RXFP2) is a GPCR known for its role in reproductive function. It is structurally related to the human relaxin receptor RXFP1 and can be activated by human gene-2 (H2) relaxin as well as its cognate ligand insulin-like ...
Shoni Bruell   +9 more
doaj   +2 more sources

Insulin-like peptide 3 (INSL3) in congenital hypogonadotrophic hypogonadism (CHH) in boys with delayed puberty and adult men [PDF]

open access: yesFrontiers in Endocrinology, 2022
BackgroundDelayed puberty in males is almost invariably associated with constitutional delay of growth and puberty (CDGP) or congenital hypogonadotrophic hypogonadism (CHH).
Ali Abbara   +30 more
doaj   +2 more sources

Generation of a heterozygous C-peptide-mCherry reporter human iPSC line (HMGUi001-A-8)

open access: yesStem Cell Research, 2021
The peptide hormone insulin produced by pancreatic β-cells undergoes post-transcriptional processing before secretion. In particular, C-peptide is cleaved from pro-insulin to generate mature insulin. Here, we introduce a C-peptide-mCherry human iPSC line
Johanna Siehler   +7 more
doaj   +1 more source

Gubernaculum and Epididymo-Testicular Descent: Review of the Literature

open access: yesActa Medica Lituanica, 2022
Cryptorchidism is a common disorder in boys that has been widely studied both experimentally and clinically. The role of the gubernaculum, a mesenchymal tissue extending from the fetal testis and epididymis to the developing scrotum, is still unclear ...
Eleonora Ivanova   +3 more
doaj   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis

open access: yesFrontiers in Endocrinology, 2021
ObjectiveNon-alcoholic fatty liver disease is highly prevalent in patients with type 2 diabetes mellitus. Studies on glucagon-like peptide-1 receptor agonists for the treatment of non-alcoholic fatty liver disease have reported promising results. Despite
Chloe Wong   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy